The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Pathway and Target Identification for Alzheimer's Disease Related Dementias (ADRDs) (U01 Clinical Trial Not Allowed)
The purpose of the FOA is to support the large scale molecular platform analysis of brain tissue, human biofluid or human induced pluripotent stem cell resources for the identification of targets and pathways associated with Alzheimer's Disease Related Dementias (ADRDs) pathophysiology.
- Letter of Intent Due Date(s): 30 days prior to the application due date
- Application Due Date(s): April 16, 2018
PAR-18-661 Expiration Date April 17, 2018